Valley Baptist Taking Appointments for Enrollment 
Assistance in Harlingen and Brownsville

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

BROWNSVILLE / HARLINGEN – With only a few days left for uninsured individuals to enroll in the new federal healthcare marketplace, the latest Kaiser Health tracking poll finds that 6 in 10 Americans without health insurance coverage are unaware that this coming Monday, March 31 is the last day to sign up under the exchanges.

Valley Baptist Medical Center-Brownsville and Valley Baptist Medical Center-Harlingen encourage Valley residents to be aware of the impending deadline to enroll in the healthcare exchanges.  Residents can call 866-893-8446 and speak with a “Path to Health” counselor for information and enrollment assistance, or to schedule an appointment with a certified enrollment counselor at Valley Baptist in Brownsville or Harlingen.  Valley Baptist-Brownsville and Valley Baptist-Harlingen will be continuing to take appointments for enrollment assistance through April 15, for those who began the application process before the deadline, and who need additional assistance.

Additionally, Valley Baptist certified enrollment counselors will join the local non-profit organization “Lupe” at San Juan Municipal Park on Saturday, March 29 to help with enrollment efforts.

- Advertisement -

Valley Baptist’s efforts to educate uninsured individuals in the Valley before the deadline is part of the national “Path to Health” campaign, a community education and outreach initiative to raise awareness and understanding of the Affordable Care Act (ACA).   For more information, visit www.PathToHealth.com or call toll-free 1-866-893-8446.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.
- Advertisement -